content

For companies in the early stages of developing a new parenteral therapy, the focus within the product teams is naturally on the molecule and...

Novavax announced that Switzerland’s Federal Office of Public Health (FOPH) and France’s Haute Autorité de Santé (HAS) have expanded their recommendations for use of...

Evaxion Biotech A/S , a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies,  announces that the Company has signed a Vaccine Discovery...

Pfizer Inc. and BioNTech SE announced the U.S. FDA granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third...

Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110...

HitGen Inc announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. , a biopharmaceutical company deploying its NITROME platform to...

Kuehne+Nagel has entered into a long-term agreement for a new airside facility strategically located in the airport zone of OR Tambo International airport, Johannesburg,...